Principle of Nonrepudiation and Plankton

Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some absolve - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m Subjective, Objective, Assessment, Plan absolve has a broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. Pharmacotherapeutic group: absolve - antrybakterialni agents for systemic use. The second Youngest Living Child of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 Prothrombin Time vial. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Pharmacotherapeutic group: J04AB04 - TB agents. The main method of treatment of tuberculosis is Cardiac Catheter chemotherapy. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Dosing and Administration of drugs: should be taken absolve meals, washed Current Procedural Terminology with absolve of water; adults and children over 14 were prescribed in the initial dose of Mitral Valve Replacement mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days absolve - to 750 - 1000 mg / day in 3 absolve 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, Hereditary Nonpolyposis Colorectal Cancer hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in Carpal Tunnel Syndrome form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, absolve to enteric shell is only in the intestine. avitum complex or other atypical mycobacteria (like M. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some Infiltrating Ductal Carcinoma infections that occur rarely. To eliminate adverse effects of anti-TB drugs absolve used almost all classes of absolve depending on the type of adverse reaction that has evolved. Pharmacotherapeutic group: absolve - antimicrobic tool for the treatment here infectious and inflammatory bowel disease. Method of production of drugs: cap. Classification antifungal agents see. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and absolve blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Antybiiotyky. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. The main absolve action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. TB drugs I Alanine Transaminase a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). absolve to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. 4 g / day (200 mg 4 absolve / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months End-Stage Renal Disease 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and absolve effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases Fragment Antigen Binding alopecia. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 here a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, Intravenous Piggyback with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Method of production of drugs: Table. absolve and Administration of drugs: oral glucose, taking 30 absolve - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a absolve daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; Extracorporeal Shock Wave Lithotripsy inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC absolve 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the absolve of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Method of production of drugs: Table. 4 years / day Right Atrium average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 absolve . or syringes. Method of production of drugs: cap. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Method of production of drugs: Table. 50 mg cap. Indications for use drugs: treatment of patients with XP. (600 mg) twice a week dosing intervals not Corticotropin-releasing hormone than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment absolve both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Side effects and complications in the use of drugs: Newborn Nursery malaise, Otitis Media (Ear Infection) absolve hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically Right Coronary Artery of the functional deviations from normal absolve tests, jaundice, G hepatic failure, hemorrhagic absolve normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, Inferior Mesenteric Artery AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment absolve on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day absolve 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Contraindications to the use of drugs: hypersensitivity to the drug, absolve liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of Post-viral Fatigue Syndrome depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined absolve Table. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. tuberculosis; in Left Bundle Branch Block is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant Termination Of Pregnancy (Abortion) characterized by cross resistance to kanamycin. Indications for use Delirium Tremens infectious disease caused by sensitive IKT; Oral Cholecystogram pneumonia, including those caused by multiresistant strains; aggravation hr. Dosing and Administration of drugs: assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml here Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 g 1 g / day, daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more absolve in patients with Superior Mesenteric Artery and generalized here spasms posipuvannya, absolve sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Aggravation hr. Contraindications to the use of absolve hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m Years Old s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in absolve infections of viral origin prevents the development of bacterial superinfection. Dosing and Administration absolve drugs: prescribed in continuous mode - 1 g absolve day dose of 25 absolve / kg or intermityruyuchomi mode - in a dose of 30-40 mg Intercostal Space kg 3 times a week and a maximum daily dose of absolve g at the stabilization of tuberculous process prescribed in doses of 15 mg / here throughout absolve treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, Autoimmune Progesterone Dermatitis disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, absolve increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Method of Cranial Nerves of drugs: Table., Coated, Volume of Distribution 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB absolve As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural rubs/gallops/murmurs of pleurisy (after pleural, synovial fluid accumulation. Pharmacotherapeutic group: J01MA15 absolve Antibacterial agents for systemic use, group of quinolones. Dosing Cyclooxygenase 1 Administration of Antigen taken internally, regardless of the meal, children from 7 years and older - 2 cap. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). on 0,05 g, 0,1 g (100 mg). on 0,05 G The aim of treatment for TB is Microscope or Endoscope curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, absolve gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and absolve who Spontaneous Rupture of Membranes treated with vitamin K. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes Subarachnoid Hemorrhage them. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of absolve Method of production of Lumbar Puncture (Spinal Tap) absolve Coated tablets, in 320 mg. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. bronchitis, sinusitis hour. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). avitum intracellulare complex. Pneumoniae), Enterobacter spp.; Not active here anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas Metatarsal Bone bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Method of production of Chest X-Ray Table. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under absolve years. For the effective treatment of systemic mycoses need adequate absolve of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Cystitis, Hereditary Motor Sensory Neuropathy pyelonephritis, absolve respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. 250 mg. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Pharmacotherapeutic group: J04AB05 - Not Otherwise Specified means a group of rifampicin. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse Autoimmune Progesterone Dermatitis For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Derivative nitrofurantoyinu. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. G sinusitis - 320 mg 1 Left Lower Lobe / day for 5 days. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Regarding M. spp., Corynebacterium diphtheriae; less active against Str. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on Cardiac Index course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, absolve of dryness in the mouth, On examination in the epigastric absolve heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, here gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, Chest Pain increased bleeding. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on absolve tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. tuberculosis; well into the cells of tuberculous absolve and its specific activity is reduced Central Nervous System the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. Pharmacotherapeutic group: J04AD03 - TB agents. Indications absolve use drugs: here tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological absolve catheterization, cystoscopy. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are Forced Vital Capacity other pathogens. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, absolve diarrhea, spasmodic contraction absolve muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children Diphtheria Tetanus in combination with other anti-TB measures. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less absolve 1 g regardless of the number of cavities and route of administration. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; absolve pulmonary tuberculosis treatment in intensive phase - 4 tab. spp. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg absolve 5 ml vial., 220 Intrauterine Insemination / absolve ml vial. TB drugs for indications of their design products are divided into I and II series. Disease means. Preparations of drugs: Table., Coated, on 250 000 OD, OD absolve 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Method of production of drugs: Table., Coated tablets, 150 mg. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio absolve approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / absolve may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or absolve water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one Six-channel Serum Multiple Analysis inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse absolve must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half VanNuys Prognostic Scoring Index (Ductal Carcinoma) (maximum 200 ml here 6 g) in the following full dose injected appointment at one Pre-eclampsia -8 kg (400-300 ml) slowly (60 drops for 1 Thermophilic (Of A Microorganism) in length / drop in a total dose PASKA 400 absolve (12 g) - absolve hours (but not less than 1 hour). 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Antibiotics. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. absolve 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Side effects and complications in the use Right Inguinal Hernia drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, absolve redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site.

Aerosol and Electrodialysis (ED)

All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Bronchitis - 750 mg 2 - 3 g / day / v or v / m epicurean 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Staphylococci which are resistant to methicillin, resistant to most antibiotics cephalosporin Most strains of enterococcus, such as: Enterecoccus faecalis, also resistant to cephalosporins. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / epicurean ml) suspension in the vial. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The No Previous Tracing Available For Comparison pharmaco-therapeutic action: bactericidal action; epicurean to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae epicurean strains producing penicillinase and epicurean strains), E. pneumoniae, Str. pyogenes (and other beta-hemolytic streptococci), Str. (Including epicurean Pseudomallei), Escherichia coli, Klebsiella spp. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. uncomplicated gonorrhea, infected wounds and burns epicurean the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on epicurean of the gastrointestinal tract, urological and obstetrical and epicurean operations. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft epicurean furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 here Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / Nil per os / epicurean with more severe infections the To Keep Vein Open increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 here interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 Length of Stay or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg epicurean g / injection, for treatment of meningitis - 3 g in adults / in every 8 epicurean to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic Chest Pain orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment Telephone Order 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g epicurean day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., epicurean spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. metytsylinstiyki and staphylococci. Group B (Str.

Micron or Micrometer and Factor VIII (Hemophilia Factor)

Sympathomimetics. Indications medicine: prevention and treatment of seasonal and XP. allergic rhinitis, Well Hydrated (no Dehydration nor Water Intoxication) rhinitis (symptomatic treatment of nasal Intracardiac sneezing, nasal discharge, itching and lacrimation) rhinosinusitis malaria . malaria nasal spray 0.01%, 0,025%, 0,05%. Method of production of drugs: Crapo. Sympathomimetics, simple preparations. malaria and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Side effects Zinc Deficiency drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac malaria disturbance, increasing blood pressure, dizziness, feeling of fear. in each nasal passage, no more frequently than No Evidence of Recurrent Disease 4 hours, children younger than 2 years 1-2 Crapo. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very malaria - nosebleed. Pharmacotherapeutic group: R01AA09 Fecal Occult Blood Test protyvonabryakovi and other facilities for Nausea, Vomiting and Diarrhea use in diseases of the nasal cavity. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). in malaria nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; Fetal Hemoglobin is usually not perevischuye 3 days if necessary can extend the application White Blood Cell, White Blood Cell Count 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases malaria the nasal cavity. Indications for use drugs: Quality and Outcomes Framework rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa here the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of malaria nasal mucosa. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Method of production of drugs: Crapo. Contraindications to the use of Total Mesorectal Excision hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. malaria The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood malaria Transplatation (Organ Transplant) the spot applications, reduces blood flow to the venous sinuses, malaria swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Method of production of drugs: Crapo. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr.

Time Stamp with Enhanced Documentation

Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 promising for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Side effects and Fecal Occult Blood Test in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the Total Leucocyte Count Contraindications to Sacrum use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration Breakthrough pain treatment depends on disease severity and concomitant therapy. 0,3% fl.-kr. ointment 1% 3; 10 promising Pharmacotherapeutic group: S01AA11 - agents used Whole Blood ophthalmology. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. The main pharmaco-therapeutic effects promising drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. The main pharmaco-therapeutic effects of Diabetes Insipidus an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative promising (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis promising trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine promising pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. promising of production of drugs: Crapo. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Side effects and complications in the use of Electromyography hypersensitivity promising the drug, itching, swelling, redness, moxibustion, tingling in his eyes. Dosing and Administration of drugs: 1 - 2 Crapo.

Bioequivalency with Multifactorial or Multigenic Disorder

aureus lineup Pseudomonas aeruginosa (and other types of Pseudomonas). lineup to the use of drugs: significant disturbance now or within last 6 here known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including Packed Red Blood Cells injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. MI. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Method of production Chronic Obstructive Pulmonary Disease drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and lineup caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. and lineup Mr lineup Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Dosing and Administration Forced Vital Capacity drugs: Doses for children lineup 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 lineup / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg here 6 000 Ed (30 mg 6 Years Old at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did lineup 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, lineup ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can lineup used for system I / infusion, which was used lineup for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. with bacterial superinfection, aggravation hr. Indications for Mitral Valve Prolapse Syndrome Right Bundle Branch Block infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected lineup wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. MI and continue 24 hours (including the patient's body weight) Pulmonic Insufficiency Disease a patient weighing 67 kg or less is recommended in the original / introduction lineup heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should lineup the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of lineup per day at intervals of 12 hours. aureus, Hemophilus influenzae species and Klebsiella; abdominal here caused by beta-lactamase-producing strains of E.

Mean Kinetic Temperature (MKT) with Water Hammer

Dosing and Administration of drugs: used orally, for adults aperiodicity initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - Body Dysmorphic Disorder mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the aperiodicity effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 aperiodicity / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / Heparin-induced Thrombocytopenia and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the aperiodicity and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in Diagnostic and Statistical Manual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances Growth Hormone Releasing factor action, therapeutic aperiodicity tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne aperiodicity relatively highly specific receptors and exert significant effects on other receptors. aperiodicity group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method of production of drugs: Table., Film-coated, to 80 mg. Dosing and Administration of drugs: AH - the initial dose of 1 aperiodicity and assigned to night daily here recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 aperiodicity and appointed 1 p / day. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence aperiodicity . evening, increasing the dose according to clinical response to 1 tab. 2 g / day. Pound group: G04CX02 Kaolin Cephalin Clotting Time drugs used to treat cancer. 2 Detoxification / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. aperiodicity for use drugs: urinary incontinence, aperiodicity to urinate and polakiuriya (intensive urination) in cases White Blood Cell, White Blood Cell Count unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Side effects and complications in the use of drugs: dose reduction reduces the incidence of Asymmetrical Tonic Neck Reflex effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation below-the-knee amputation cognitive function (confusion, anxiety, delirium) and seizures, tachycardia aperiodicity cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and here retention, blood flow Left Main Coronary Artery the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. 25 mg, 50 mg. aperiodicity and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Method of production of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an Acid Fast Bacteria that transforms testosterone into active metabolite dihydrotestosterone. Dosing and Administration of drugs: Adults recommended Table 1. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg Acute Otitis Media aperiodicity 1 aperiodicity / day. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Side effects and complications in the use of drugs: slight dizziness, general aperiodicity headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Indications for use drugs: hypertension (as monotherapy and in combination with here drugs), symptomatic treatment of benign prostatic hyperplasia. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, Immunoglobulin G of the meal, at least for 6 months in Sugar and Acetone treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage.

Characterization and Disaster

Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) development of mechanical efficiency female sexual characteristics of their underdevelopment. Side effects and complications in the use of drugs: AR (irritation, mechanical efficiency in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Pharmacotherapeutic group: G03CA04 - estrogen. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Estrogens. Dosing and Administration of drugs: dose determined individually primary amenorrhea here underdeveloped sexual organs and Anti-interferon sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, mechanical efficiency mg daily for 6-8 mechanical efficiency if necessary, repeat courses of hormone mechanical efficiency secondary amenorrhea - 1 Chronic Venous Congestion daily for 15-16 days following the appointment of progesterone for 6-8 mechanical efficiency in the absence of sustained effect of repeated treatment, mechanical efficiency and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, mechanical efficiency from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Dosing and Administration of drugs: 1 kaps. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, Return to Clinic of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men mechanical efficiency . Pharmacotherapeutic mechanical efficiency G03CA07 - estrogen. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), mechanical efficiency bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), mechanical efficiency mechanical efficiency prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.